101691-65-0 Usage
Description
(Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulphonate is a chemical compound that belongs to the category of organic compounds known as Pyrans. These compounds contain a pyran ring, which is a six-member aromatic heterocycle composed of one oxygen atom and five carbon atoms. Although there is limited information available on its typical uses or properties, it is likely to possess unique reactivity, solubility, and stability characteristics defined by its distinctive molecular structure. It may have potential applications in the field of organic synthesis or pharmaceuticals, but further chemical analysis and experimentation would be required to confirm its specific uses.
Uses
Used in Organic Synthesis:
(Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulphonate is used as a chemical intermediate for the synthesis of various organic compounds. Its unique molecular structure allows it to participate in a range of chemical reactions, making it a valuable component in the development of new molecules with potential applications in various industries.
Used in Pharmaceutical Industry:
(Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulphonate is used as a potential building block in the design and synthesis of new pharmaceutical compounds. Its distinctive structure may contribute to the development of novel drugs with improved efficacy, safety, and selectivity, although further research and testing would be necessary to validate its suitability for this application.
Check Digit Verification of cas no
The CAS Registry Mumber 101691-65-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,6,9 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 101691-65:
(8*1)+(7*0)+(6*1)+(5*6)+(4*9)+(3*1)+(2*6)+(1*5)=100
100 % 10 = 0
So 101691-65-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H18O4S/c1-11-2-4-13(5-3-11)18(14,15)17-10-12-6-8-16-9-7-12/h2-5,12H,6-10H2,1H3
101691-65-0Relevant articles and documents
5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
-
Page/Page column 90-91; 73, (2021/04/17)
Provided herein are compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
8-substituted styryl xanthine derivative and application thereof
-
Paragraph 0268; 0270-0272; 0659; 0661-0663, (2020/05/01)
The invention discloses an 8-substituted styryl xanthine derivative and application thereof, and particularly relates to a novel 8-substituted styryl xanthine derivative and a pharmaceutical composition containing the compound, and the 8-substituted styryl xanthine derivative can be used as a selective adenosine A2A receptor antagonist. The invention also relates to a method for preparing the compound and the pharmaceutical composition, and application of the compound and the pharmaceutical composition in preparation of drugs for treating adenosine A2A receptor related diseases, especially Parkinson's disease.
Palladium-Catalyzed Atom-Transfer Radical Cyclization at Remote Unactivated C(sp3)?H Sites: Hydrogen-Atom Transfer of Hybrid Vinyl Palladium Radical Intermediates
Ratushnyy, Maxim,Parasram, Marvin,Wang, Yang,Gevorgyan, Vladimir
supporting information, p. 2712 - 2715 (2018/03/02)
A novel mild, visible-light-induced palladium-catalyzed hydrogen atom translocation/atom-transfer radical cyclization (HAT/ATRC) cascade has been developed. This protocol involves a 1,5-HAT process of previously unknown hybrid vinyl palladium radical intermediates, thus leading to iodomethyl carbo- and heterocyclic structures.
